• ქართული
  • English
  • Abbvie settles Humira patent disputes with Novartis unit

    Abbvie Inc said on Thursday it settled all patent disputes with Novartis AG, granting it a non-exclusive license to manufacture and sell a copycat version of blockbuster drug, Humira.

    Market Quotes by TradingView